Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
Abroad (travel likely)Recruiting
Conditions
Ischemic Stroke · CYP2C19 Polymorphism
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Drew Weko, MPH)
Study leads
Rachael M Stone, PharmD
Principal Investigator
University of Virginia